4-aminopyridine has been researched along with ergoline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bowyer, JF; Weiner, N | 1 |
Barrett, JE; Rosenzweig-Lipson, S | 1 |
O'Malley, KL; Tang, L; Todd, RD | 1 |
3 other study(ies) available for 4-aminopyridine and ergoline
Article | Year |
---|---|
K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes.
Topics: 1-Methyl-3-isobutylxanthine; 4-Aminopyridine; Adenylate Cyclase Toxin; Adenylyl Cyclases; Aminopyridines; Animals; Calcium; Colforsin; Dopamine; Ergolines; Ethylmaleimide; In Vitro Techniques; Pertussis Toxin; Potassium Channels; Quinpirole; Rats; Synaptosomes; Tetraethylammonium Compounds; Virulence Factors, Bordetella | 1989 |
K-channel blockers attenuate the presynaptic effects of the D2/D3 agonist quinpirole in monkeys.
Topics: 4-Aminopyridine; Amodiaquine; Animals; Apamin; Behavior, Animal; Catalepsy; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Male; Potassium Channels; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Presynaptic; Saimiri | 1995 |
Dopamine D2 and D3 receptors inhibit dopamine release.
Topics: 4-Aminopyridine; Animals; Cell Line; Dopamine; Ergolines; Humans; Membrane Potentials; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Tetraethylammonium; Tetraethylammonium Compounds | 1994 |